Clinical Trial Update: Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial conducted by Göteborg University evaluating omega-3/omega-6 fatty acids for Attention-Deficit/Hyperactivity Disorder in children and adolescents h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Specific Learning Disorder

Drugs mentioned

• Omega-3/Omega-6 Fatty Acids (Omega-3 and Omega-6 fatty acids)

Snippet

Sponsor: Göteborg University | Conditions: ADHD, Reading/Writing Disorder | Phase 3 | Status: COMPLETED